MedPath

Comparison of 2 group of anaesthetic drugs,propofol-ketamine and propofol- dexmedetomidine to provide general anaesthesia and observe & compare change in vitals like blood pressure , heart rate and recovery profile like emergence, orientation time in patients undergoing laparoscopic cholecystectomy

Phase 3
Not yet recruiting
Conditions
Calculus of gallbladder without cholecystitis,
Registration Number
CTRI/2020/10/028483
Lead Sponsor
Jawaharlal Nehru hospital and research centre
Brief Summary

This is a comparative study of two anaesthetic drug combination propofol-ketamine and propofol-dexmedetomidine in terms of hemodynamic variables like heart rate,blood pressure and recovery characteristics in two study groups of patients undergoing laparoscopic cholecystectomy under general anaesthesia. It will be conducted in department of anaesthesiology, JLNHRC  and it is hospital based, time bound, prospective, comparative randomised control trial and sample size is 56 patients undergoing laparoscopic cholecystectomy. Two groups of 28 patients each will be made. After taking consent and pre anaesthetic checkup and preparation for ot, Patient will receive loading dose of either iv ketamine or iv dexmedetomidine before induction with propofol and surgery will be started. Intraoperative  hemodynamic variables like heart rate , mean arterial blood pressure , systolic blood pressure, diastolic blood pressure will be measured every 10 mins interval till the end of surgery and Recovery characteristics including emergence time, response to commands time, orientation time, Ramsay sedation score at 0min 30 min 60 min 90 min 120 min;  VAS score  at 0 hour ,1 , 2, 3, 4, 6, 8,10, 12, 18, 24th hour; first analgesic time; recovery discharge time will be noted and compared  as per the objective of the study. All data will be analysed statistically.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
56
Inclusion Criteria

ASA I and ASA II Both genders Age from 18 years to 60 years Patients undergoing laparoscopic cholecystectomy.

Exclusion Criteria
  • Age below 18 years and above 60 years ASA III and ASA IV Pregnant or breast.
  • feeding patient Patients with baseline heart rate less than 55/minute Patients with hypertension, heart blocks and ischemic heart diseases Allergic to study drugs Laparoscopic cholecystectomy converted to open cholecystectomy Patient with severe hepatic, renal, endocrine and cardiac dysfunction Patient refusal to participate in the study Patients on sedatives, psychiatric medications, opioid therapy.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Which among the two drug combination has better hemodynamic stability and recovery characteristics. Comparison in terms of Intraoperative hemodynamic variables including heart rate , mean arterial blood pressure , systolic blood pressure, diastolic blood pressure and Recovery characteristicsIntraoperative heart rate , mean arterial blood pressure , systolic blood pressure, diastolic blood pressure measured every 10 mins interval . Recovery characteristics including emergence time, response to commands time, orientation time, Ramsay sedation score at 0min 30 min 60 min 90 min 120 min; VAS score at 0 hour ,1 , 2, 3, 4, 6, 8,10, 12, 18, 24th hour; first analgesic time; recovery discharge
Secondary Outcome Measures
NameTimeMethod
Hemodynamics , Recovery profile, post operative analgesic requirement, PACU stayIntraoperative hemodynamic variables like heart rate , mean arterial blood pressure every 10 mins interval . Recovery characteristics including emergence time, response to commands time, orientation time, Ramsay sedation score at 0min 30 min 60 min 90 min 120 min; VAS score at 0 hour ,1 , 2, 3, 4, 6, 8,10, 12, 18, 24th hour; first analgesic time; recovery discharge

Trial Locations

Locations (1)

Jawaharlal Nehru hospital and research centre

🇮🇳

Durg, CHHATTISGARH, India

Jawaharlal Nehru hospital and research centre
🇮🇳Durg, CHHATTISGARH, India
Priya Pankaj
Principal investigator
8984796602
priyapankaj1802@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.